Poly-ADP-ribose polymerases (PARPs) as a therapeutic target in the treatment of selected cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Poly-ADP-ribose polymerases (PARPs) as a therapeutic target in the treatment of selected cancers

Published:2019-08-13 Issue:9 Volume:23 Page:773-785
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Przybycinski Jarosław¹,Nalewajska Magdalena¹,Marchelek-Mysliwiec Małgorzata¹,Dziedziejko Violetta²,Pawlik Andrzej³

Affiliation:

1. Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, Szczecin, Poland

2. Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, Szczecin, Poland

3. Department of Physiology, Pomeranian Medical University, Szczecin, Poland

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2019.1654458

Reference107 articles.

1. DNA Repair: From Genome Maintenance to Biomarker and Therapeutic Target

2. Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP

3. Insights into the binding of PARP inhibitors to the catalytic domain of human tankyrase-2

4. Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate

5. The Potential of PARP Inhibitors in Genetic Breast and Ovarian Cancers

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patents on PARP-1 Inhibitors for the Management of Cancer from 2017-2023;Recent Patents on Anti-Cancer Drug Discovery;2024-06-13

2. Discovery of Potent Isoindolinone Inhibitors that Target an Active Conformation of PARP1 Using DNA‐Encoded Libraries;ChemMedChem;2024-04-09

3. PARP-2 mediates cardiomyocyte aging and damage induced by doxorubicin through SIRT1 Inhibition;Apoptosis;2024-01-28

4. Ocular side effects of oncological therapies: Review;Archivos de la Sociedad Española de Oftalmología (English Edition);2023-11

5. Efectos secundarios oculares de las terapias oncológicas. Revisión;Archivos de la Sociedad Española de Oftalmología;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3